drug
as of 2026-07-01URB597
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Central Institute of Mental Health, Mannheim
1 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
small molecule
Indications
Investigational (via trials)
Trials
1
Evaluation Study of New Compounds With Potential Use in Schizophrenia
NCT00916201Phase 1Withdrawn
KOLs & investigators
1
F. Markus Leweke, MDKOL score 9
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here